Survival Trends and Prognostic Modeling in ALK‐Positive Anaplastic Large Cell Lymphoma: A Population‐Based Study in the Brentuximab Vedotin Era

ABSTRACT Background ALK‐positive anaplastic large cell lymphoma (ALK+ ALCL) is a rare subtype of peripheral T‐cell lymphoma with traditionally favorable prognosis. The introduction of brentuximab vedotin (BV) has significantly impacted treatment outcomes, but the long‐term survival trends and predic...

Full description

Bibliographic Details

Main Authors:	Qiuyu Zhang, Yanyan Liu
Format:	Artigo
Language:	Inglês
Published:	Wiley 2026-03-01
Series:	Cancer Medicine
Subjects:	ALK‐positive anaplastic large cell lymphoma brentuximab vedotin machine learning random survival forest SEER database
Online Access:	https://doi.org/10.1002/cam4.71695
Tags:	Add Tag No Tags, Be the first to tag this record!